Mediclinic International PLC (MDC) Receives Average Rating of “Hold” from Brokerages

Shares of Mediclinic International PLC (LON:MDC) have earned a consensus rating of “Hold” from the six brokerages that are covering the company, MarketBeat reports. Four analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is GBX 488.80 ($6.39).

A number of equities analysts have recently commented on the company. Barclays dropped their price objective on Mediclinic International from GBX 700 ($9.15) to GBX 660 ($8.62) and set an “overweight” rating on the stock in a research note on Friday, September 28th. Citigroup upgraded Mediclinic International to a “buy” rating in a research note on Tuesday, October 2nd. HSBC upgraded Mediclinic International to a “hold” rating and dropped their price objective for the stock from GBX 540 ($7.06) to GBX 390 ($5.10) in a research note on Thursday, October 25th. Finally, JPMorgan Chase & Co. upgraded Mediclinic International to an “overweight” rating and dropped their price objective for the stock from GBX 480 ($6.27) to GBX 394 ($5.15) in a research note on Monday, January 7th.

Shares of Mediclinic International stock traded up GBX 4.90 ($0.06) during trading on Monday, reaching GBX 335.20 ($4.38). The company’s stock had a trading volume of 1,410,715 shares, compared to its average volume of 1,610,000. Mediclinic International has a one year low of GBX 495.40 ($6.47) and a one year high of GBX 890.18 ($11.63).

The company also recently declared a dividend, which was paid on Tuesday, December 18th. Investors of record on Thursday, December 6th were paid a dividend of GBX 3.20 ($0.04) per share. The ex-dividend date of this dividend was Thursday, December 6th. This represents a yield of 0.93%.

Mediclinic International Company Profile

Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers acute care, specialist-orientated, and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 17 private acute care hospitals and 4 clinics with approximately 1,805 inpatient beds in Switzerland; 49 acute care private hospitals and 2 day clinics in South Africa, and 3 hospitals in Namibia with approximately 8,131 inpatient beds; and 6 acute care private hospitals and 22 clinics with approximately 748 inpatient beds in the United Arab Emirates.

Read More: Why is the ex-dividend date different from the record date?

Analyst Recommendations for Mediclinic International (LON:MDC)

Receive News & Ratings for Mediclinic International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International and related companies with's FREE daily email newsletter.

Leave a Reply